Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Tuberculosis immunity: opportunities from studies with cattle.

Waters WR, Palmer MV, Thacker TC, Davis WC, Sreevatsan S, Coussens P, Meade KG, Hope JC, Estes DM.

Clin Dev Immunol. 2011;2011:768542. doi: 10.1155/2011/768542. Epub 2010 Dec 6. Review.

2.

Relevance of bovine tuberculosis research to the understanding of human disease: historical perspectives, approaches, and immunologic mechanisms.

Waters WR, Maggioli MF, McGill JL, Lyashchenko KP, Palmer MV.

Vet Immunol Immunopathol. 2014 Jun 15;159(3-4):113-32. doi: 10.1016/j.vetimm.2014.02.009. Epub 2014 Feb 22.

PMID:
24636301
3.

Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.

Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, Morris SL.

Clin Vaccine Immunol. 2010 May;17(5):793-801. doi: 10.1128/CVI.00006-10. Epub 2010 Mar 31.

4.

Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.

Lin MY, Geluk A, Smith SG, Stewart AL, Friggen AH, Franken KL, Verduyn MJ, van Meijgaarden KE, Voskuil MI, Dockrell HM, Huygen K, Ottenhoff TH, Klein MR.

Infect Immun. 2007 Jul;75(7):3523-30. Epub 2007 May 14.

5.

Novel particulate vaccines utilizing polyester nanoparticles (bio-beads) for protection against Mycobacterium bovis infection - a review.

Parlane NA, Rehm BH, Wedlock DN, Buddle BM.

Vet Immunol Immunopathol. 2014 Mar 15;158(1-2):8-13. doi: 10.1016/j.vetimm.2013.04.002. Epub 2013 Apr 30. Review.

PMID:
23707076
6.

Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.

Triccas JA, Shklovskaya E, Spratt J, Ryan AA, Palendira U, Fazekas de St Groth B, Britton WJ.

Infect Immun. 2007 Nov;75(11):5368-75. Epub 2007 Aug 27.

7.

Mycobacterium bovis Δmce2 double deletion mutant protects cattle against challenge with virulent M. bovis.

Blanco FC, Bianco MV, Garbaccio S, Meikle V, Gravisaco MJ, Montenegro V, Alfonseca E, Singh M, Barandiaran S, Canal A, Vagnoni L, Buddle BM, Bigi F, Cataldi A.

Tuberculosis (Edinb). 2013 May;93(3):363-72. doi: 10.1016/j.tube.2013.02.004. Epub 2013 Mar 19.

PMID:
23518075
8.

Evaluation of granulysin and perforin as candidate biomarkers for protection following vaccination with Mycobacterium bovis BCG or M. bovisDeltaRD1.

Capinos Scherer CF, Endsley JJ, de Aguiar JB, Jacobs WR Jr, Larsen MH, Palmer MV, Nonnecke BJ, Ray Waters W, Mark Estes D.

Transbound Emerg Dis. 2009 Aug;56(6-7):228-39. doi: 10.1111/j.1865-1682.2008.01058.x. Epub 2009 Mar 11.

PMID:
19389081
9.

Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.

Liang J, Teng X, Yuan X, Zhang Y, Shi C, Yue T, Zhou L, Li J, Fan X.

Mol Immunol. 2015 Aug;66(2):392-401. doi: 10.1016/j.molimm.2015.04.017. Epub 2015 May 18.

PMID:
25974877
11.

Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis.

Pérez de Val B, Villarreal-Ramos B, Nofrarías M, López-Soria S, Romera N, Singh M, Abad FX, Xing Z, Vordermeier HM, Domingo M.

Clin Vaccine Immunol. 2012 Sep;19(9):1339-47. doi: 10.1128/CVI.00275-12. Epub 2012 Jul 3.

12.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
13.

Development of vaccines to control bovine tuberculosis in cattle and relationship to vaccine development for other intracellular pathogens.

Buddle BM, Pollock JM, Skinner MA, Wedlock DN.

Int J Parasitol. 2003 May;33(5-6):555-66. Review.

PMID:
12782055
14.

DIVA reagents for bovine tuberculosis vaccines in cattle.

Vordermeier M, Jones GJ, Whelan AO.

Expert Rev Vaccines. 2011 Jul;10(7):1083-91. doi: 10.1586/erv.11.22. Review.

PMID:
21806401
15.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
16.

Mycobacterium bovis antigens for the differential diagnosis of vaccinated and infected cattle.

Vordermeier M, Gordon SV, Hewinson RG.

Vet Microbiol. 2011 Jul 5;151(1-2):8-13. doi: 10.1016/j.vetmic.2011.02.020. Epub 2011 Feb 24.

PMID:
21411245
17.

A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.

Li W, Deng G, Li M, Zeng J, Zhao L, Liu X, Wang Y.

Mol Immunol. 2014 Nov;62(1):86-95. doi: 10.1016/j.molimm.2014.06.007. Epub 2014 Jun 28.

PMID:
24980867
18.

Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves.

Waters WR, Palmer MV, Nonnecke BJ, Thacker TC, Scherer CF, Estes DM, Hewinson RG, Vordermeier HM, Barnes SW, Federe GC, Walker JR, Glynne RJ, Hsu T, Weinrick B, Biermann K, Larsen MH, Jacobs WR Jr.

Vaccine. 2009 Feb 18;27(8):1201-9. doi: 10.1016/j.vaccine.2008.12.018. Epub 2009 Jan 9.

19.
20.

Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.

Lu M, Xia ZY, Bao L.

Cell Immunol. 2013 Sep-Oct;285(1-2):111-7. doi: 10.1016/j.cellimm.2013.10.001. Epub 2013 Oct 11.

PMID:
24177251

Supplemental Content

Support Center